QC
REGN icon

QCM Cayman’s Regeneron Pharmaceuticals REGN Stock Holding History

QCM Cayman’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-201
Closed -$211K – 32
2024
Q2 		$211K Buy
+201
New +$195K 2.28% 23
2023
Q4 		– Sell
-256
Closed -$211K – 47
2023
Q3 		$211K Sell
256
-150
-37% -$118K 1.37% 41
2023
Q2 		$292K Buy
+406
New +$313K 1.71% 24
2022
Q4 		– Sell
-422
Closed -$291K – 58
2022
Q3 		$291K Buy
+422
New +$266K 4.25% 5
2022
Q2 		– Sell
-513
Closed -$358K – 80
2022
Q1 		$358K Buy
513
+72
+16% +$45.6K 1.57% 17
2021
Q4 		$279K Buy
+441
New +$271K 1.69% 23
2021
Q3 		– Sell
-449
Closed -$251K – 159
2021
Q2 		$251K Buy
+449
New +$227K 0.65% 68
2017
Q4 		– Sell
-553
Closed -$247K – 196
2017
Q3 		$247K Sell
553
-42
-7% -$20K 0.63% 78
2017
Q2 		$292K Buy
+595
New +$260K 0.67% 67
2016
Q3 		– Sell
-717
Closed -$250K – 317
2016
Q2 		$250K Buy
+717
New +$276K 0.11% 168
2015
Q2 		– Sell
-549
Closed -$248K – 237
2015
Q1 		$248K Buy
+549
New +$233K 0.13% 143
2014
Q3 		– Sell
-1,875
Closed -$530K – 262
2014
Q2 		$530K Buy
+1,875
New +$556K 0.25% 71

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

QCM Cayman's REGN Position: Q3 2024 in Review

QCM Cayman sold out of Regeneron Pharmaceuticals (REGN) in Q3 2024, closing a stake of 201 shares — an estimated $211K sold.

QCM Cayman first reported a position in REGN in Q2 2014 and held it in 12 quarters. The position peaked at $530K in Q2 2014. 1,389 funds tracked by Wall St. Rank hold REGN as of Q3 2024.

  • QCM Cayman reported no remaining Regeneron Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • QCM Cayman sold 201 Regeneron Pharmaceuticals shares in Q3 2024, an estimated $211K.
  • QCM Cayman first reported a position in Regeneron Pharmaceuticals in Q2 2014 and held it in 12 quarters.
  • QCM Cayman's Regeneron Pharmaceuticals position peaked at $530K in Q2 2014.
  • 1,389 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2024.

Based on QCM Cayman's 13F filing for Q3 2024, filed 4 Nov 2024.